Research output per year
Research output per year
Fingerprint
Dive into the research topics where Yuka Hayashi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection
Tajiri, K., Hayashi, Y., Murayama, A., Muraishi, N., Minemura, M. & Yasuda, I., 2025/01, In: Viruses. 17, 1, 44.Research output: Contribution to journal › Article › peer-review
Open Access -
Wilson’s Disease Suspected to Involve a Novel Genetic Mutation of ATP7B Gene, Requiring a Differential Diagnosis with Non-alcoholic Steatohepatitis
Minemura, M., Fukuda, R., Tajiri, K., Muraishi, N., Murayama, A., Hayashi, Y., Takahara, T., Noguchi, A. & Yasuda, I., 2025, In: Internal Medicine. 64, 3, p. 375-379 5 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Impact of post-progression survival in second-line treatment with molecular target agents for unresectable hepatocellular carcinoma
Tajiri, K., Muraishi, N., Murayama, A., Hayashi, Y. & Yasuda, I., 2024/04, In: Hepatology Research. 54, 4, p. 403-408 6 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus Infection
Hayashi, Y., Tajiri, K., Ozawa, T., Angata, K., Sato, T., Togayachi, A., Nagashima, I., Shimizu, H., Murayama, A., Muraishi, N., Narimatsu, H. & Yasuda, I., 2024/08, In: Medicina (Lithuania). 60, 8, 1334.Research output: Contribution to journal › Article › peer-review
Open Access -
Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma
Tajiri, K., Tsukada, K., Tokimitsu, Y., Motofuji, Y., Kawai, K., Muraishi, N., Murayama, A., Hayashi, Y., Shimizu, Y. & Yasuda, I., 2024/02/01, In: Oncology (Switzerland). 102, 2, p. 131-140 10 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Datasets
-
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Tajiri, K. (Creator), Okada, K. (Creator), Ito, H. (Creator), Kawai, K. (Creator), Kashii, Y. (Creator), Tokimitsu, Y. (Creator), Muraishi, N. (Creator), Murayama, A. (Creator), Hayashi, Y. (Creator), Minemura, M. (Creator), Takahara, T. (Creator), Shimizu, Y. (Creator) & Yasuda, I. (Creator), figshare, 2023
DOI: 10.6084/m9.figshare.c.6665748, https://springernature.figshare.com/collections/Long_term_changes_in_thrombocytopenia_and_leucopenia_after_HCV_eradication_with_direct-acting_antivirals/6665748
Dataset
-
Supplementary Material for: Objective response and progression free survival contribute to prolong overall survival in atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma.
Tajiri, K. (Contributor), Tsukada, K. (Contributor), Tokimitsu, Y. (Contributor), Motofuji, Y. (Contributor), Kawai, K. (Contributor), Muraishi, N. (Contributor), Murayama, A. (Contributor), Hayashi, Y. (Contributor), Shimizu, Y. (Contributor) & Yasuda, I. (Contributor), Karger Publishers, 2023
DOI: 10.6084/m9.figshare.24080436, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Objective_response_and_progression_free_survival_contribute_to_prolong_overall_survival_in_atezolizumab_plus_bevacizumab_treatment_for_unresectable_hepatocellular_carcinoma_/24080436
Dataset
-
Supplementary Material for: An autopsy of ruptured hepatic angiosarcoma treated by transcatheter arterial embolization
Entani, T. (Contributor), Tajiri, K. (Contributor), Noguchi, A. (Contributor), Murayama, A. (Contributor), Muraishi, N. (Contributor), Hayashi, Y. (Contributor) & Yasuda, I. (Contributor), Karger Publishers, 2023
DOI: 10.6084/m9.figshare.24259993, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_An_autopsy_of_ruptured_hepatic_angiosarcoma_treated_by_transcatheter_arterial_embolization/24259993
Dataset
-
Supplementary Material for: Objective response and progression free survival contribute to prolong overall survival in atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma.
Tajiri, K. (Contributor), Tsukada, K. (Contributor), Tokimitsu, Y. (Contributor), Motofuji, Y. (Contributor), Kawai, K. (Contributor), Muraishi, N. (Contributor), Murayama, A. (Contributor), Hayashi, Y. (Contributor), Shimizu, Y. (Contributor) & Yasuda, I. (Contributor), Karger Publishers, 2023
DOI: 10.6084/m9.figshare.24080436.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Objective_response_and_progression_free_survival_contribute_to_prolong_overall_survival_in_atezolizumab_plus_bevacizumab_treatment_for_unresectable_hepatocellular_carcinoma_/24080436/1
Dataset
-
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Tajiri, K. (Creator), Okada, K. (Creator), Ito, H. (Creator), Kawai, K. (Creator), Kashii, Y. (Creator), Tokimitsu, Y. (Creator), Muraishi, N. (Creator), Murayama, A. (Creator), Hayashi, Y. (Creator), Minemura, M. (Creator), Takahara, T. (Creator), Shimizu, Y. (Creator) & Yasuda, I. (Creator), figshare, 2023
DOI: 10.6084/m9.figshare.c.6665748.v1, https://springernature.figshare.com/collections/Long_term_changes_in_thrombocytopenia_and_leucopenia_after_HCV_eradication_with_direct-acting_antivirals/6665748/1
Dataset